Congenital hyperinsulinism: 2 case reports with different rare variants in ABCC8
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Congenital hyperinsulinism (CHI) is a rare glucose metabolism disorder characterized by unregulated secretion of insulin that leads to hyperinsulinemic hypoglycemia (HH). Most cases are caused by mutations in the KATP-channel genes ABCC8 and KCNJ11. We report 2 patients that experienced severe HH from the first day of life. Patient 1 developed midgut volvulus after initiating diazoxide and required intestinal resection. He was subsequently managed with a high-dose octreotide and glucose-enriched diet. Consistent with diffuse type CHI by 18F-dihydroxyphenylalanine positron emission tomography-computed tomography, genetic testing revealed a homozygous ABCC8 variant, c.1801G>A, p.(Val601Ile). The rare variant was previously reported to be diazoxide-responsive, and the patient responded well to diazoxide monotherapy, with clinical remission at 2 years of age. Patient 2 responded to diazoxide with spontaneous clinical remission at 15 months of age. However, an oral glucose tolerance test at 7 years of age revealed hyperinsulinism. Genetic testing revealed that the proband and several seemingly healthy family members harbored a novel, heterozygous ABCC8 variant, c.1780T>C, p.(Ser594Pro). Genetic findings identified previously unrecognized HH in the proband’s mother. The proband’s uncle had been diagnosed with monogenic ABCC8-diabetes and was successfully transitioned from insulin to glibenclamide therapy. We report findings of intestinal malrotation and volvulus occurring 2 days after initiation of diazoxide treatment. We also report a novel, heterozygous ABCC8 variant in a family that exhibited cases of CHI in infancy and HH and monogenic diabetes in adult members. The cases demonstrate the importance and clinical utility of genetic analyses for informing and guiding treatment and care.
Abstract
Congenital hyperinsulinism (CHI) is a rare glucose metabolism disorder characterized by unregulated secretion of insulin that leads to hyperinsulinemic hypoglycemia (HH). Most cases are caused by mutations in the KATP-channel genes ABCC8 and KCNJ11. We report 2 patients that experienced severe HH from the first day of life. Patient 1 developed midgut volvulus after initiating diazoxide and required intestinal resection. He was subsequently managed with a high-dose octreotide and glucose-enriched diet. Consistent with diffuse type CHI by 18F-dihydroxyphenylalanine positron emission tomography-computed tomography, genetic testing revealed a homozygous ABCC8 variant, c.1801G>A, p.(Val601Ile). The rare variant was previously reported to be diazoxide-responsive, and the patient responded well to diazoxide monotherapy, with clinical remission at 2 years of age. Patient 2 responded to diazoxide with spontaneous clinical remission at 15 months of age. However, an oral glucose tolerance test at 7 years of age revealed hyperinsulinism. Genetic testing revealed that the proband and several seemingly healthy family members harbored a novel, heterozygous ABCC8 variant, c.1780T>C, p.(Ser594Pro). Genetic findings identified previously unrecognized HH in the proband’s mother. The proband’s uncle had been diagnosed with monogenic ABCC8-diabetes and was successfully transitioned from insulin to glibenclamide therapy. We report findings of intestinal malrotation and volvulus occurring 2 days after initiation of diazoxide treatment. We also report a novel, heterozygous ABCC8 variant in a family that exhibited cases of CHI in infancy and HH and monogenic diabetes in adult members. The cases demonstrate the importance and clinical utility of genetic analyses for informing and guiding treatment and care.
참고문헌 (20)
- Bellanné-Chantelot C, "ABCC8 and KCNJ11molecular spectrum of 109 patients with diazoxideunresponsive congenital hyperinsulinism", J Med Genet, 47, pp.752~759 (2010)
- Kapoor RR, "Clinical and molecular characterisation of 300patients with congenital hyperinsulinism", Eur J Endocrinol, 168, pp.557~564 (2013)
- Roženková K, "The diagnosis and management of hyperinsulinaemic hypoglycaemia", J Clin Res Pediatr Endocrinol, 7, pp.86~97 (2015)
- Helleskov A, "Both low blood glucose and insufficient treatment confer risk of neurodevelopmental impairment in congenital hyperinsulinism : a multinational cohort study", Front Endocrinol, 8, pp.156~ (2017)
- R asmussen AG, "The difficult management of persistent, non-focal congenital hyperinsulinism : a retrospective review from a single, tertiary center", Pediatr Diabetes, 21, pp.441~455 (2020)
- Tohru Yorifuji, "Congenital hyperinsulinism: current status and future perspectives", Annals of Pediatric Endocrinology & Metabolism, 19(2), pp.57~68 (2014), 대한소아내분비학회
- Gillis D., "GeneReviews®", pp.1993~2020, University of Washington
- Vajravelu ME, "Genetic characteristics of patients with congenital hyperinsulinism", Curr Opin Pediatr, 30, pp.568~575 (2018)
- Flanagan SE, "Genetics of congenital hyperinsulinemic hypoglycemia", Semin Pediatr Surg, 20, pp.13~17 (2011)
- Martínez R, "Clinical and genetic characterization of congenital hyperinsulinism in Spain", Eur J Endocrinol, 174, pp.717~726 (2016)
- Mohamed Z, "Hyperinsulinaemic hypoglycaemia : genetic mechanisms, diagnosis and management", J Clin Res Pediatr Endocrinol, 4, pp.169~168 (2012)
- Rahman SA, "Molecular mechanisms of congenital hyperinsulinism", J Mol Endocrinol, 54, pp.R119~R129 (2015)
- Misra S, "Genetics of monogenic diabetes : present clinical challenges", Curr Diab Rep, 18, pp.141~ (2018)
- Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med Off J Am Coll Med Genet, 17, pp.405~424 (2015)
- Arya VB, "Clinical and histological heterogeneity of congenital hyperinsulinism due to paternally inherited heterozygous ABCC8", KCNJ11 mutations, 2014, pp.171, 685~695
- Strouse PJ, "Disorders of intestinal rotation and fixation(«malrotation »)", Pediatr Radiol, 34, pp.837~851 (2004)
- Salehi Karlslätt K, "Rare copy number variants contribute pathogenic alleles in patients with intestinal malrotation", Mol Genet Genomic Med, 7, pp.e549~ (2019)
- Kapoor RR, "Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8", KCNJ11mutations, 2011, pp.54, 2575~2583
- Vieira TC, "Hyperinsulinemic hypoglycemia evolving to gestational diabetes and diabetes mellitus in a family carrying the inactivating ABCC8 E1506K mutation", Pediatr Diabetes, 11, pp.505~508 (2010)
- Ortiz D, "Neonatal diabetes and congenital hyperinsulinism caused by mutations in ABCC8", SUR1 are associated with altered and opposite affinities for ATP and ADP, 2015, pp.6, 48~